BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33450312)

  • 1. Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca
    Alomar FA; Tian C; Dash PK; McMillan JM; Gendelman HE; Gorantla S; Bidasee KR
    Antiviral Res; 2021 Mar; 187():104975. PubMed ID: 33450312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2).
    Alomar FA; Tian C; Bidasee SR; Venn ZL; Schroder E; Palermo NY; AlShabeeb M; Edagwa BJ; Payne JJ; Bidasee KR
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dust from hog confinement facilities impairs Ca2+ mobilization from sarco(endo)plasmic reticulum by inhibiting ryanodine receptors.
    Tian C; Moore CJ; Dodmane P; Shao CH; Romberger DJ; Toews ML; Bidasee KR
    J Appl Physiol (1985); 2013 Mar; 114(5):665-74. PubMed ID: 23288552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
    Bannister RA; Beam KG
    J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.
    Lefebvre R; Legrand C; Groom L; Dirksen RT; Jacquemond V
    PLoS One; 2013; 8(1):e54042. PubMed ID: 23308296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ritonavir, atazanavir and their combination on the CYP3A4 induction potential of efavirenz in primary human hepatocytes.
    Mugundu GM; Hariparsad N; Desai PB
    Drug Metab Lett; 2010 Jan; 4(1):45-50. PubMed ID: 20201776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
    Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
    Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects.
    Calderón MM; Penzak SR; Pau AK; Kumar P; McManus M; Alfaro RM; Kovacs JA
    Clin Infect Dis; 2016 Apr; 62(8):1036-1042. PubMed ID: 26797214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression levels of RyR1 and RyR3 control resting free Ca2+ in skeletal muscle.
    Perez CF; López JR; Allen PD
    Am J Physiol Cell Physiol; 2005 Mar; 288(3):C640-9. PubMed ID: 15548569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox modification of ryanodine receptor contributes to impaired Ca
    Agrawal A; Rathor R; Kumar R; Suryakumar G; Singh SN; Kumar B
    Free Radic Biol Med; 2020 Nov; 160():643-656. PubMed ID: 32916280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
    Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
    J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Ca(2+) sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin.
    Fruen BR; Bardy JM; Byrem TM; Strasburg GM; Louis CF
    Am J Physiol Cell Physiol; 2000 Sep; 279(3):C724-33. PubMed ID: 10942723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient High-Throughput Screening by Endoplasmic Reticulum Ca
    Murayama T; Kurebayashi N; Ishigami-Yuasa M; Mori S; Suzuki Y; Akima R; Ogawa H; Suzuki J; Kanemaru K; Oyamada H; Kiuchi Y; Iino M; Kagechika H; Sakurai T
    Mol Pharmacol; 2018 Jul; 94(1):722-730. PubMed ID: 29674523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
    Avila G; Dirksen RT
    J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldolase potentiates DIDS activation of the ryanodine receptor in rabbit skeletal sarcoplasmic reticulum.
    Seo IR; Moh SH; Lee EH; Meissner G; Kim DH
    Biochem J; 2006 Oct; 399(2):325-33. PubMed ID: 16817780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
    Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevoflurane modulation of Ca2+ regulation in skeletal muscle sarcoplasmic reticulum vesicles from young and mature rabbits.
    König M; Lin M; Nelson TE; Groban L
    Paediatr Anaesth; 2009 Dec; 19(12):1166-74. PubMed ID: 19863735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [3H]ryanodine receptors and Ca++ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum.
    Zimányi I; Pessah IN
    J Pharmacol Exp Ther; 1991 Mar; 256(3):938-46. PubMed ID: 1848635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K201 (JTV519) is a Ca2+-Dependent Blocker of SERCA and a Partial Agonist of Ryanodine Receptors in Striated Muscle.
    Darcy YL; Diaz-Sylvester PL; Copello JA
    Mol Pharmacol; 2016 Aug; 90(2):106-15. PubMed ID: 27235390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid signalling inhibits sarcoplasmic Ca
    Oláh T; Bodnár D; Tóth A; Vincze J; Fodor J; Reischl B; Kovács A; Ruzsnavszky O; Dienes B; Szentesi P; Friedrich O; Csernoch L
    J Physiol; 2016 Dec; 594(24):7381-7398. PubMed ID: 27641745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.